International Journal of Hematology

Title Publication Date Language Citations
Chimeric antigen receptors for the adoptive T cell therapy of hematologic malignancies2013/12/06English78
Regulation of myelopoiesis by the transcription factor IRF82015/03/07English78
The mechanisms of cancer immunoescape and development of overcoming strategies2011/03/01English77
Romiplostim for the treatment of chronic immune thrombocytopenia in adult Japanese patients: a double-blind, randomized Phase III clinical trial2011/06/25English76
A role for RUNX1 in hematopoiesis and myeloid leukemia2013/04/24English76
Current status of HTLV-1 infection2011/10/04English75
Leukemic stem cells: identification and clinical application2017/03/29English73
Low-dose rituximab combined with short-term glucocorticoids up-regulates Treg cell levels in patients with immune thrombocytopenia2010/12/29English73
Significant alterations in the epidemiology and treatment outcome of invasive fungal infections in patients with hematological malignancies2008/11/05English71
Overexpression of Annexin II affects the proliferation, apoptosis, invasion and production of proangiogenic factors in multiple myeloma2009/07/08English71
Mesenchymal stromal cell therapy for steroid-refractory acute and chronic graft versus host disease: a phase 1 study2011/12/20English71
Diffuse large B-cell lymphoma with central nervous system relapse: prognosis and risk factors according to retrospective analysis from a single-center experience2009/04/09English71
C/EBPα in normal and malignant myelopoiesis2015/03/10English71
How we treat chronic active Epstein–Barr virus infection2017/02/16English70
2019 Updated diagnostic criteria and disease severity classification for TAFRO syndrome2019/11/28English69
IgG4-producing marginal zone B-cell lymphoma2008/10/08English69
Endoplasmic-reticulum stress pathway-associated mechanisms of action of proteasome inhibitors in multiple myeloma2016/05/12English68
High maximum standard uptake value (SUVmax) on PET scan is associated with shorter survival in patients with diffuse large B cell lymphoma2011/04/01English68
Deeper molecular response is a predictive factor for treatment-free remission after imatinib discontinuation in patients with chronic phase chronic myeloid leukemia: the JALSG-STIM213 study2017/09/19English67
Early development of human hematopoietic and acquired immune systems in new born NOD/Scid/Jak3null mice intrahepatic engrafted with cord blood-derived CD34+ cells2008/11/28English67
Cellular players of hematopoietic stem cell mobilization in the bone marrow niche2016/12/10English66
Myeloid neoplasms with germline DDX41 mutation2017/05/25English66
Integrated analysis of long-term safety in patients with chronic immune thrombocytopaenia (ITP) treated with the thrombopoietin (TPO) receptor agonist romiplostim2015/07/23English65
Iron overload in myelodysplastic syndromes (MDS)2017/11/25English65
Diagnostic and treatment guidelines for thrombotic thrombocytopenic purpura (TTP) 2017 in Japan2017/05/26English64
Incidence and survival rates of hematological malignancies in Japanese children and adolescents (2006–2010): based on registry data from the Japanese Society of Pediatric Hematology2013/05/24English64
Unrelated allogeneic bone marrow-derived mesenchymal stem cells for steroid-refractory acute graft-versus-host disease: a phase I/II study2013/07/17English64
Factor XIII is a key molecule at the intersection of coagulation and fibrinolysis as well as inflammation and infection control2012/04/01English64
Targeting Smad4 links microRNA-146a to the TGF-β pathway during retinoid acid induction in acute promyelocytic leukemia cell line2010/06/25English63
Increase in myeloid-derived suppressor cells (MDSCs) associated with minimal residual disease (MRD) detection in adult acute myeloid leukemia2015/09/10English63